{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:11:50Z","timestamp":1651687910793},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12185-018-2506-3","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T08:55:58Z","timestamp":1532422558000},"page":"416-422","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method"],"prefix":"10.1007","volume":"108","author":[{"given":"Hidekazu","family":"Itamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Sueoka-Aragane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaburo","family":"Sueoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Masunari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Suzumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"2506_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V27.2.199.199","volume":"27","author":"R Schrek","year":"1966","unstructured":"Schrek R, Donnelly WJ. \u201cHairy\u201d cells in blood in lymphoreticular neoplastic disease and \u201cflagellated\u201d cells of normal lymph nodes. Blood. 1966;27:199\u2013211.","journal-title":"Blood"},{"key":"2506_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hon.975","volume":"29","author":"F Forconi","year":"2011","unstructured":"Forconi F. Hairy cell leukaemia: biological and clinical overview from immunogenetic insights. Hematol Oncol. 2011;29:55\u201366.","journal-title":"Hematol Oncol"},{"key":"2506_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2141.2011.08931.x","volume":"156","author":"G Jones","year":"2012","unstructured":"Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D. Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. Br J Haematol. 2012;156:186\u201395.","journal-title":"Br J Haematol"},{"key":"2506_CR4","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: World Heal. Organ. Classification Tumours Haematop. Lymphoid Tissue; 2008."},{"key":"2506_CR5","first-page":"3605","volume":"50","author":"L Bernstein","year":"1990","unstructured":"Bernstein L, Newton P, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res. 1990;50:3605\u20139.","journal-title":"Cancer Res"},{"key":"2506_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1600-0609.2006.00732.x","volume":"77","author":"O Paltiel","year":"2006","unstructured":"Paltiel O, Adler B, Barchana M, Dann EJ. A population-based study of hairy cell leukemia in Israel. Eur J Haematol. 2006;77:372\u20137.","journal-title":"Eur J Haematol"},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0145-2126(80)90066-1","volume":"4","author":"JC Cawley","year":"1980","unstructured":"Cawley JC, Burns GF, Hayhoe FGJ. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leuk Res. 1980;4:547\u201359.","journal-title":"Leuk Res"},{"key":"2506_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2169\/internalmedicine1962.29.379","volume":"29","author":"T Machii","year":"1990","unstructured":"Machii T, Tokumine Y, Inoue R, Kitani T. A unique variant of hairy cell leukemia in Japan. Jpn J Med. 1990;29:379\u201383.","journal-title":"Jpn J Med"},{"key":"2506_CR9","first-page":"181","volume":"7","author":"T Machii","year":"1993","unstructured":"Machii T, Tokumine Y, Inoue R, Kitani T. Predominance of a distinct subtype of hairy cell leukemia in Japan. Leukemia. 1993;7:181\u20136.","journal-title":"Leukemia"},{"key":"2506_CR10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1182\/blood.V89.6.2008","volume":"89","author":"T Machii","year":"1997","unstructured":"Machii T, Yamaguchi M, Inoue R, Tokumine Y, Kuratsune H, Nagai H, et al. Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant. Blood. 1997;89:2008.","journal-title":"Blood"},{"key":"2506_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"2506_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305\u201315.","journal-title":"N Engl J Med"},{"key":"2506_CR13","doi-asserted-by":"publisher","first-page":"238ra71","DOI":"10.1126\/scitranslmed.3008004","volume":"6","author":"SS Chung","year":"2014","unstructured":"Chung SS, Kim E, Park JH, Chung YR, Lito P, Teruya-Feldstein J, et al. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia. Sci Transl Med. 2014;6:238ra71\u20131.","journal-title":"Sci Transl Med"},{"key":"2506_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","volume":"119","author":"L Arcaini","year":"2012","unstructured":"Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012;119:188\u201391.","journal-title":"Blood"},{"key":"2506_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1182\/blood-2011-08-371179","volume":"119","author":"E Tiacci","year":"2012","unstructured":"Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2012;119:192\u20135.","journal-title":"Blood"},{"key":"2506_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12253-016-0121-2","volume":"23","author":"M Ide","year":"2017","unstructured":"Ide M, Koba S, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, et al. Mutation profile of B-Raf gene analyzed by fully automated system and clinical features in japanese melanoma patients. Pathol Oncol Res. 2017;23:181\u20138.","journal-title":"Pathol Oncol Res"},{"key":"2506_CR17","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.leukres.2007.12.019","volume":"32","author":"R Tanaka","year":"2008","unstructured":"Tanaka R, Kuroda J, Stevenson W, Ashihara E, Ishikawa T, Taki T, et al. Fully automated and super-rapid system for the detection of JAK2V617F mutation. Leuk Res. 2008;32:1462\u20137.","journal-title":"Leuk Res"},{"key":"2506_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2169\/internalmedicine.54.2944","volume":"54","author":"K Okada","year":"2015","unstructured":"Okada K, Kunitomi A, Sakai K, Muranushi H, Okamoto Y, Tsukamoto T, et al. Hairy cell leukemia with systemic lymphadenopathy: detection of BRAF mutations in both lymph node and peripheral blood specimens. Intern Med. 2015;54:1397\u2013402.","journal-title":"Intern Med"},{"key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","volume":"373","author":"E Tiacci","year":"2015","unstructured":"Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, et al. Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N Engl J Med. 2015;373:1733\u201347.","journal-title":"N Engl J Med"},{"key":"2506_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1056\/NEJMc1310849","volume":"370","author":"J Samuel","year":"2014","unstructured":"Samuel J, Macip S, Dyer MJS. Efficacy of vemurafenib in hairy-cell leukemia. N Engl J Med. 2014;370:286\u20138.","journal-title":"N Engl J Med"},{"key":"2506_CR21","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMc1202124","volume":"366","author":"S Dietrich","year":"2012","unstructured":"Dietrich S, Glimm H, Andrulis M, von Kalle C, Ho AD, Zenz T. BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med. 2012;366:2038\u201340.","journal-title":"N Engl J Med"},{"key":"2506_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ijo.2015.2978","volume":"47","author":"SI Suzuki","year":"2015","unstructured":"Suzuki SI, Matsusaka S, Hirai M, Shibata H, Takagi K, Mizunuma N, et al. A novel approach to detect KRAS\/BRAF mutation for colon cancer: highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction. Int J Oncol. 2015;47:97\u2013105.","journal-title":"Int J Oncol"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12253-009-9161-1","volume":"15","author":"Y Hashimoto","year":"2009","unstructured":"Hashimoto Y, Tsukamoto N, Nakahashi H, Yokohama A, Saitoh T, Handa H, et al. Hairy cell leukemia-related disorders consistently show low CD27 expression. Pathol Oncol Res. 2009;15:615\u201321.","journal-title":"Pathol Oncol Res"},{"key":"2506_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<316::AID-AJH13>3.0.CO;2-B","volume":"52","author":"GJ Ruiz-Arg\u00fcelles","year":"1996","unstructured":"Ruiz-Arg\u00fcelles GJ, Cant\u00fa-Rodr\u00edguez OG, G\u00f3mez-Almaguer D, Certes-Franco J, G\u00f3ngora-Biachi RA, Pizzuto J, et al. Hairy cell leukemia is infrequent in Mexico and has a geographic distribution. Am J Hematol. 1996;52:316\u20138.","journal-title":"Am J Hematol"},{"key":"2506_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1099-1069(200012)18:4<155::AID-HON668>3.0.CO;2-H","volume":"18","author":"WY Au","year":"2000","unstructured":"Au WY, Kwong YL, Ma SK, Mak YK, Wong KF, Lei KI, et al. Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey. Hematol Oncol. 2000;18:155\u20139.","journal-title":"Hematol Oncol"},{"key":"2506_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000328887","volume":"126","author":"H-W Kao","year":"2011","unstructured":"Kao H-W, Dunn P, Kuo M-C, Shih L-Y, Lin T-L, Wu J-H, et al. Classical hairy cell leukemia and its variant: a 17-year retrospective survey in Taiwan Chinese. Acta Haematol. 2011;126:186\u201393.","journal-title":"Acta Haematol"},{"key":"2506_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.5790514.x","volume":"67","author":"K Tamura","year":"2001","unstructured":"Tamura K, Sawada H, Izumi Y, Fukuda T, Utsunomiya A, Ikeda S, et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol. 2001;67:152\u20137.","journal-title":"Eur J Haematol"},{"key":"2506_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164:536\u201345.","journal-title":"Br J Haematol"},{"key":"2506_CR29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V82.4.1277.1277","volume":"82","author":"BA Robbins","year":"1993","unstructured":"Robbins BA, Ellison DJ, Spinosa JC, Carey CA, Lukes RJ, Poppema S, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood. 1993;82:1277\u201387.","journal-title":"Blood"},{"key":"2506_CR30","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1182\/blood-2009-01-201731","volume":"114","author":"E Arons","year":"2009","unstructured":"Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood. 2009;114:4687\u201395.","journal-title":"Blood"},{"key":"2506_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.2828","volume":"46","author":"JJ Waterfall","year":"2014","unstructured":"Waterfall JJ, Arons E, Walker RL, Pineda M, Roth L, Killian JK, et al. High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias. Nat Genet. 2014;46:8\u201310 (Nature Publishing Group).","journal-title":"Nat Genet"},{"key":"2506_CR32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","volume":"5","author":"E Shtivelman","year":"2014","unstructured":"Shtivelman E, Davies MQa, Hwu P, Yang J, Lotem M, Oren M, et al. Pathways and therapeutic targets in melanoma. Oncotarget. 2014;5:1701\u201352.","journal-title":"Oncotarget"},{"key":"2506_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12885-015-1276-z","volume":"15","author":"A Kawazoe","year":"2015","unstructured":"Kawazoe A, Shitara K, Fukuoka S, Kuboki Y, Bando H, Okamoto W, et al. A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer. BMC Cancer. 2015;15:258\u201366.","journal-title":"BMC Cancer"},{"key":"2506_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio J. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:6\u20138.","journal-title":"Blood"},{"key":"2506_CR35","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","volume":"120","author":"J Haroche","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L, Von Deimling A, H\u00e9lias-rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses brief report high prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700\u20133.","journal-title":"Blood"},{"key":"2506_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12185-013-1437-2","volume":"98","author":"P Szturz","year":"2013","unstructured":"Szturz P, Hlavat\u00fd L, Pr\u00e1\u0161ek J, Dvo\u0159\u00e1kov\u00e1 D. Erdheim\u2013Chester disease and Schnitzler syndrome: so near, and yet so far. Int J Hematol. 2013;98:379\u201381.","journal-title":"Int J Hematol"},{"key":"2506_CR37","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","volume":"121","author":"J Haroche","year":"2013","unstructured":"Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim\u2013Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121:1495\u2013500.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2506-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T15:18:31Z","timestamp":1604675911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2506-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2506-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}